These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 25642938)

  • 1. Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers.
    Goyenvalle A; Griffith G; Babbs A; El Andaloussi S; Ezzat K; Avril A; Dugovic B; Chaussenot R; Ferry A; Voit T; Amthor H; Bühr C; Schürch S; Wood MJ; Davies KE; Vaillend C; Leumann C; Garcia L
    Nat Med; 2015 Mar; 21(3):270-5. PubMed ID: 25642938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Antisense Oligonucleotides for the Treatment of Duchenne Muscular Dystrophy.
    Relizani K; Goyenvalle A
    Methods Mol Biol; 2018; 1687():171-183. PubMed ID: 29067663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Tricyclo-DNA Antisense Oligonucleotides for Exon Skipping.
    Relizani K; Goyenvalle A
    Methods Mol Biol; 2018; 1828():381-394. PubMed ID: 30171555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model.
    Relizani K; Griffith G; Echevarría L; Zarrouki F; Facchinetti P; Vaillend C; Leumann C; Garcia L; Goyenvalle A
    Mol Ther Nucleic Acids; 2017 Sep; 8():144-157. PubMed ID: 28918017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Impact of Variable Phosphorothioate Content in Tricyclo-DNA Antisense Oligonucleotides in a Duchenne Muscular Dystrophy Mouse Model.
    Echevarría L; Aupy P; Relizani K; Bestetti T; Griffith G; Blandel F; Komisarski M; Haeberli A; Svinartchouk F; Garcia L; Goyenvalle A
    Nucleic Acid Ther; 2019 Jun; 29(3):148-160. PubMed ID: 31009315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy.
    Koo T; Wood MJ
    Hum Gene Ther; 2013 May; 24(5):479-88. PubMed ID: 23521559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.
    Maruyama R; Aoki Y; Takeda S; Yokota T
    Methods Mol Biol; 2018; 1828():365-379. PubMed ID: 30171554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exon 51 Skipping Quantification by Digital Droplet PCR in del52hDMD/mdx Mice.
    Hiller M; Spitali P; Datson N; Aartsma-Rus A
    Methods Mol Biol; 2018; 1828():249-262. PubMed ID: 30171546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing Effective Antisense Oligonucleotides for Exon Skipping.
    Shimo T; Maruyama R; Yokota T
    Methods Mol Biol; 2018; 1687():143-155. PubMed ID: 29067661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.
    Hanson B; Wood MJA; Roberts TC
    RNA Biol; 2021 Jul; 18(7):1048-1062. PubMed ID: 33472516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscular dystrophy: New exon-skipping strategy rescues dystrophin.
    Crunkhorn S
    Nat Rev Drug Discov; 2015 Apr; 14(4):236. PubMed ID: 25829275
    [No Abstract]   [Full Text] [Related]  

  • 12. DMD genotype correlations from the Duchenne Registry: Endogenous exon skipping is a factor in prolonged ambulation for individuals with a defined mutation subtype.
    Wang RT; Barthelemy F; Martin AS; Douine ED; Eskin A; Lucas A; Lavigne J; Peay H; Khanlou N; Sweeney L; Cantor RM; Miceli MC; Nelson SF
    Hum Mutat; 2018 Sep; 39(9):1193-1202. PubMed ID: 29907980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy.
    Miskew Nichols B; Aoki Y; Kuraoka M; Lee JJ; Takeda S; Yokota T
    J Vis Exp; 2016 May; (111):. PubMed ID: 27285612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dystrophic Duchenne mouse model for testing human antisense oligonucleotides.
    Veltrop M; van Vliet L; Hulsker M; Claassens J; Brouwers C; Breukel C; van der Kaa J; Linssen MM; den Dunnen JT; Verbeek S; Aartsma-Rus A; van Putten M
    PLoS One; 2018; 13(2):e0193289. PubMed ID: 29466448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednisolone treatment does not interfere with 2'-O-methyl phosphorothioate antisense-mediated exon skipping in Duchenne muscular dystrophy.
    Verhaart IE; Heemskerk H; Karnaoukh TG; Kolfschoten IG; Vroon A; van Ommen GJ; van Deutekom JC; Aartsma-Rus A
    Hum Gene Ther; 2012 Mar; 23(3):262-73. PubMed ID: 22017442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic Peptides to Improve Delivery and Exon Skipping of Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy.
    Jirka SMG; 't Hoen PAC; Diaz Parillas V; Tanganyika-de Winter CL; Verheul RC; Aguilera B; de Visser PC; Aartsma-Rus AM
    Mol Ther; 2018 Jan; 26(1):132-147. PubMed ID: 29103911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.
    Heemskerk HA; de Winter CL; de Kimpe SJ; van Kuik-Romeijn P; Heuvelmans N; Platenburg GJ; van Ommen GJ; van Deutekom JC; Aartsma-Rus A
    J Gene Med; 2009 Mar; 11(3):257-66. PubMed ID: 19140108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy.
    Kemaladewi DU; Hoogaars WM; van Heiningen SH; Terlouw S; de Gorter DJ; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; ten Dijke P; 't Hoen PA
    BMC Med Genomics; 2011 Apr; 4():36. PubMed ID: 21507246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy.
    Dzierlega K; Yokota T
    Gene Ther; 2020 Sep; 27(9):407-416. PubMed ID: 32483212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide conjugation of 2'-O-methyl phosphorothioate antisense oligonucleotides enhances cardiac uptake and exon skipping in mdx mice.
    Jirka SM; Heemskerk H; Tanganyika-de Winter CL; Muilwijk D; Pang KH; de Visser PC; Janson A; Karnaoukh TG; Vermue R; 't Hoen PA; van Deutekom JC; Aguilera B; Aartsma-Rus A
    Nucleic Acid Ther; 2014 Feb; 24(1):25-36. PubMed ID: 24320790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.